S. K. Sarin

Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury - results from the ICA-GLOBAL AKI study

Simone Incicco, Adrià Juanola, Kavish R. Patidar, Anna Barone et autres

it, ca, es, us, in, mx, Égypte, sg, cn, kr, pe, hu, de, br, ar, fr, ru, cl, nl, dk, il, Éthiopie, py, be, pt, ch (code pays fourni par la source)

From prognostication to therapeutics: Four key questions to accelerate the development of therapeutics for patients with acute-on-chronic liver failure

Jennifer C. Lai, S. K. Sarin

Acute-on-chronic liver failure (ACLF) has come a long way as a clinical concept within the hepatology and liver transplant communities. Though the term was proposed in 1995, the first recognition of the entity along with a consensus definition emerged in 2009. Subsequently, …

us, in, es (code pays fourni par la source)

Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis

Gui-Ji Lv, Dong Ji, Lingxiang Yu, Hongyan Chen et autres

cn, hk, tw (code pays fourni par la source)

Invasive Candida auris Infections: Epidemiology, Risk Factor Analysis and Management in Tertiary Care Hepatobiliary Centre

K. Pratibha, Niharika Patel, S. K. Sarin

in (code pays fourni par la source)

2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics

Pratibha Kale, Vikas Khillan, S. K. Sarin

Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studiede risk factors, molecular epidemiology and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics Single-center, prospective cohort study of 50 critically ill cirrhotics with …

in (code pays fourni par la source)

Albumin decreases the incidence of paracentesis induced circulatory dysfunction with less than 5 litres of ascitic tap in acute on chronic liver failure (ACLF) patients: Randomized controlled trial (NCT02467348)

Vinod Arora, Rakhi Maiwall, Sherin Thomas, V. Rajan et autres

Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure (ACLF) With Hepatic Encephalopathy (HE): A Randomized Trial (clinicaltrials.gov identifier: NCT02321371)

Tanmay Vyas, Rakhi Maiwall, Ankur Jinadal, S. K. Sarin

in (code pays fourni par la source)

Incidence, Predictors and Outcome of Acute Kidney Injury in Patients with Nosocomial Spontaneous Bacterial Peritonitis

Rakhi Maiwall, S. K. Sarin

Urinary Metabolomic Analysis or Early Prediction of Sepsis in Acute-on -Chronic Liver Failure Patients

Jaswinder Singh Maras, Stephanie L M Das, Md. Sarfaraj Hussain, Ashok Chaudhary et autres

P1114 : A metabolomics approach to identify excretory metabolite signature in patients with severe alcoholic hepatitis non responsive to Gluco-Corticosteroid therapy

Jaswinder Singh Maras, Shvetank Sharma, Sukanta Das, S. Sm et autres

in, fr (code pays fourni par la source)

A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy

Barjesh Chander Sharma, Praveen Sharma, Manish Kumar Lunia, Siddharth Srivastava et autres

OBJECTIVES: Hepatic encephalopathy (HE) is associated with poor prognosis in cirrhosis. Drugs used in the treatment of HE are primarily directed at the reduction of the blood ammonia levels. Rifaximin and lactulose have shown to be effective in HE. We evaluated the …

in (code pays fourni par la source)

939 CORRELATION OF TRANSIENT ELASTOGRAPHY (TE) WITH HEPATIC VENOUS PRESSURE GRADIENT (HVPG): A PROSPECTIVE STUDY

Abhishek Kumar, Pooja Sharma, Mukesh Kumar, Himanshu Garg et autres

gb, es (code pays fourni par la source)